Cargando…
Solriamfetol for the Use of Narcolepsy: A Systematic Review
Narcolepsy is a chronic and disabling neurological disorder characterized by excessive daytime sleepiness (EDS) and cataplexy. Historically, some medications have demonstrated efficacy in managing EDS and cataplexy symptoms. However, some patients cannot tolerate them, become refractory, or may use...
Autores principales: | Iturburu, Alisson, Pallares Vela, Elisa, Cruz, Claudio, Yepez, Mario, Ortiz, Juan Fernando, Krishna, Krithika, Peña, Gabriela, Cordova, Steven, Khurana, Mahika, Bandarupalli, Pranathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188301/ https://www.ncbi.nlm.nih.gov/pubmed/35706734 http://dx.doi.org/10.7759/cureus.24937 |
Ejemplares similares
-
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
por: Thorpy, Michael J., et al.
Publicado: (2019) -
P148 Solriamfetol Titration & AdministRaTion (START): Dosing and titration strategies in patients with narcolepsy starting solriamfetol
por: Thorpy, M, et al.
Publicado: (2021) -
Effects of solriamfetol on on‐the‐road driving in participants with narcolepsy: A randomised crossover trial
por: Vinckenbosch, Frederick, et al.
Publicado: (2022) -
Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis
por: Pacheco, Kimberly, et al.
Publicado: (2022) -
Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
por: Abad, Vivien C
Publicado: (2021)